Generic Category: VITAMIN B12
RYBELSUS is contraindicated in patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in RYBELSUS [see Adverse Reactions (6.2)]
Patients should maintain open communication with their healthcare team, reporting any new or worsening mental health symptoms promptly
Samineni R, Chimakurthy J, Konidala S (2022) Emerging role of biopharmaceutical classification and biopharmaceutical drug disposition system in dosage form development: a systematic review
Importantly, dietary habits often remain unchanged after diagnosis, suggesting that nutritional management is underappreciated in clinical care [174]
REDEFINE 1 Results (Phase 3) The landmark trial randomized 3,417 adults to CagriSema 2.4/2.4 mg, semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo for 68 weeks (Aronne et al., 2025): The combination significantly outperformed either component alone